The intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunities.

Daniel J. Silver; Maksim Sinyuk; Michael A. Vogelbaum; Manmeet S. Ahluwalia; Justin D. Lathia

doi:10.1093/NEUONC/NOV157

The intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunities.

Daniel J. Silver, Maksim Sinyuk, Michael A. Vogelbaum, Manmeet S. Ahluwalia, Justin D. Lathia

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-oncology
Volume	18
DOIs	https://doi.org/10.1093/NEUONC/NOV157
State	Published - Feb 1 2016

Disciplines

Biology
Oncology
Internal Medicine

Access to Document

10.1093/NEUONC/NOV157License: Unspecified

Cite this

@article{bfa2d6e82256443d97bbb18c032c8018,

title = "The intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunities.",

author = "Silver, \{Daniel J.\} and Maksim Sinyuk and Vogelbaum, \{Michael A.\} and Ahluwalia, \{Manmeet S.\} and Lathia, \{Justin D.\}",

note = "Despite aggressive clinical intervention including surgery, radiation, and chemotherapy, malignant brain tumors such as glioblastoma (GBM) universally progress, leading to patient mortality in an average of 12-15 months. Many factors subvert promising therapies. Cancer stem cells (CSCs) and the immune-suppressed glioma microenvironment represent 2 such factors that have recently emerged at the center of a series of investigations.",

year = "2016",

month = feb,

day = "1",

doi = "10.1093/NEUONC/NOV157",

language = "American English",

volume = "18",

journal = "Neuro-oncology",

}

TY - JOUR

T1 - The intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunities.

AU - Silver, Daniel J.

AU - Sinyuk, Maksim

AU - Vogelbaum, Michael A.

AU - Ahluwalia, Manmeet S.

AU - Lathia, Justin D.

N1 - Despite aggressive clinical intervention including surgery, radiation, and chemotherapy, malignant brain tumors such as glioblastoma (GBM) universally progress, leading to patient mortality in an average of 12-15 months. Many factors subvert promising therapies. Cancer stem cells (CSCs) and the immune-suppressed glioma microenvironment represent 2 such factors that have recently emerged at the center of a series of investigations.

PY - 2016/2/1

Y1 - 2016/2/1

UR - https://academic.oup.com/neuro-oncology/article/18/2/153/2509196

U2 - 10.1093/NEUONC/NOV157

DO - 10.1093/NEUONC/NOV157

M3 - Article

VL - 18

JO - Neuro-oncology

JF - Neuro-oncology

ER -

The intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunities.

Disciplines

Access to Document

Other files and links

Cite this